Turan Demircan

2.0k total citations · 1 hit paper
35 papers, 1.4k citations indexed

About

Turan Demircan is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Turan Demircan has authored 35 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Organic Chemistry. Recurrent topics in Turan Demircan's work include Synthesis and Biological Evaluation (4 papers), Tissue Engineering and Regenerative Medicine (3 papers) and Glioma Diagnosis and Treatment (3 papers). Turan Demircan is often cited by papers focused on Synthesis and Biological Evaluation (4 papers), Tissue Engineering and Regenerative Medicine (3 papers) and Glioma Diagnosis and Treatment (3 papers). Turan Demircan collaborates with scholars based in Türkiye, Netherlands and United States. Turan Demircan's co-authors include Hans Clevers, Inha Heo, Jeffrey M. Beekman, Nobuo Sasaki, Edward E. S. Nieuwenhuis, Edwin Cuppen, Valentina Sasselli, Gerald Schwank, Johanna F. Dekkers and Sander Boymans and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Turan Demircan

32 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Functional Repair of CFTR by CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients

2013 1.0k citations Gerald Schwank, Bon‐Kyoung Koo et al. Cell stem cell profile →

Peers

Countries citing papers authored by Turan Demircan

Since Specialization

Citations

This map shows the geographic impact of Turan Demircan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Turan Demircan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Turan Demircan more than expected).

Fields of papers citing papers by Turan Demircan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Turan Demircan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Turan Demircan. The network helps show where Turan Demircan may publish in the future.

Co-authorship network of co-authors of Turan Demircan

This figure shows the co-authorship network connecting the top 25 collaborators of Turan Demircan. A scholar is included among the top collaborators of Turan Demircan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Turan Demircan. Turan Demircan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anti-carcinogenic effects of arecaidine but-2-ynyl ester tosylate on breast cancer: proliferation inhibition and activation of apoptosis 2025 ·Molecular Biology Reports ·(unknown), (unknown), Turan Demircan	0
2	Novel benzohydrazide derivative as a potential anticarcinogenic agent for breast cancer: Synthesis, crystal structure, in vitro and in silico assessments 2024 ·Journal of Molecular Structure ·(unknown), (unknown), Turan Demircan, (unknown), Tuncer Hökelek, Ramazan Güp	1
3	mTOR Pathway Inhibition, Anticancer Activity and In Silico Calculations of Novel Hydrazone Derivatives in Two- and Three-Dimensional Cultured Type 1 Endometrial Cancer Cells 2024 ·Pharmaceuticals ·(unknown), Arif Mermer, (unknown), Fatih Kocabaş, (unknown), (unknown), Turan Demircan, İlknur Keskin	0
4	Exploring the potentials of S4, a selective androgen receptor modulator, in glioblastoma multiforme therapy 2024 ·Toxicology and Applied Pharmacology ·(unknown), Turan Demircan	1
5	PCR-based characterization of nasal and ocular surface flora and functional analysis of bacterial metabolic pathways in congenital nasolacrimal duct obstruction 2024 ·International Ophthalmology ·(unknown), Turan Demircan, Fatma Yülek, Nilay Yüksel	1
6	A selective androgen receptor modulator, S4, displays robust anti-cancer activity on hepatocellular cancer cells by negatively regulating PI3K/AKT/mTOR signalling pathway 2023 ·Gene ·(unknown), (unknown), Çığır Biray Avcı, Turan Demircan	7
7	Association between the anthropometric measurements and dietary habits on telomere shortening in healthy older adults: A‐cross‐sectional study 2023 ·Geriatrics and gerontology international ·(unknown), (unknown), Turan Demircan, (unknown), (unknown)	4
8	In vitro anti-carcinogenic effect of andarine as a selective androgen receptor modulator on MIA-PaCa-2 cells by decreased proliferation and cell-cycle arrest at G0/G1 phase 2023 ·Biochemical and Biophysical Research Communications ·(unknown), (unknown), (unknown), Çığır Biray Avcı, Turan Demircan	3
9	m ⁶ A Pathway Regulators Are Frequently Mutated in Breast Invasive Carcinoma and May Play an Important Role in Disease Pathogenesis 2021 ·OMICS A Journal of Integrative Biology ·Turan Demircan, (unknown), (unknown)	5
10	Cellular and Molecular Comparison of Glioblastoma Multiform Cell Lines 2021 ·Cureus ·Turan Demircan, (unknown), (unknown), (unknown), Ebru Altuntaş	15
11	Microbiome and Longevity: High Abundance of Longevity-Linked Muribaculaceae in the Gut of the Long-Living Rodent Spalax leucodon 2020 ·OMICS A Journal of Integrative Biology ·(unknown), Ebru Altuntaş, (unknown), Gürkan Öztürk, Süleyman Yıldırım, Turan Demircan	75
12	Dissecting the Molecular Signature of Spinal Cord Regeneration in the Axolotl Model 2020 ·Cureus ·Turan Demircan	6
13	The first report on circulating microRNAs at Pre- and Post-metamorphic stages of axolotls 2020 ·Gene ·Turan Demircan, (unknown), (unknown), Ebru Altuntaş, (unknown)	4
14	Proteome data to explore the axolotl limb regeneration capacity at neotenic and metamorphic stages 2020 ·SHILAP Revista de lepidopterología ·Turan Demircan, (unknown), Ebru Altuntaş	2
15	Comparison of protein expression profile of limb regeneration between neotenic and metamorphic axolotl 2019 ·Biochemical and Biophysical Research Communications ·(unknown), Ebru Altuntaş, Barış Ethem Süzek, Betül Şahin, (unknown), Gürkan Öztürk, Ahmet Tarık Baykal, Turan Demircan	21
16	Longitudinal 16S rRNA data derived from limb regenerative tissue samples of axolotl Ambystoma mexicanum 2019 ·Scientific Data ·Turan Demircan, (unknown), (unknown), Gürkan Öztürk, Süleyman Yıldırım	12
17	Axolotl cells and tissues enhances cutaneous wound healing in mice 2016 ·Journal of Experimental & Clinical Medicine ·Turan Demircan, İlknur Keskin, Mehmet Yalçın Günal, (unknown), (unknown), Gürkan Öztürk	1
18	A histological atlas of the tissues and organs of neotenic and metamorphosed axolotl 2016 ·Acta Histochemica ·Turan Demircan, (unknown), (unknown), (unknown), Gürkan Öztürk, İlknur Keskin	31
19	The Hippo Pathway Regulates Stem Cells During Homeostasis and Regeneration of the Flatworm Macrostomum Lignano 2013 ·Stem Cells and Development ·Turan Demircan, Eugène Berezikov	19
20	Functional Repair of CFTR by CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients breakdown → 2013 ·Cell stem cell ·Gerald Schwank, Bon‐Kyoung Koo, Valentina Sasselli, Johanna F. Dekkers, Inha Heo, Turan Demircan, Nobuo Sasaki, Sander Boymans, Edwin Cuppen, Cornelis K. van der Ent, Edward E. S. Nieuwenhuis, Jeffrey M. Beekman, Hans Clevers	1034

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact